相关实验视频
Updated: Jul 20, 2025

05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
709
美国肥胖患病率不断增加 末期脏病人口
B A Shelton1, R D Reed1, P A MacLennan1
1Comprehensive Transplant Institute, University of Alabama at Birmingham, USA.
概括
患有末期脏疾病 (ESRD) 的患者的肥胖率比普通人群上升得更快. 这一趋势影响透析存活率和脏移植机会,需要对ESRD患者制定肥胖流行病策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 末期病 (ESRD) 患者的肥胖症呈现出复杂的关系,有可能改善透析存活率,同时阻碍移植.
- 肥胖率的上升可能会显著影响透析患者人口的增长.
研究的目的:
- 为了比较体质指数 (BMI) 趋势在ESRD人口与美国一般人口.
- 分析随着时间的推移,ESRD患者的BMI增加率.
主要方法:
- 利用美国脏数据系统 (USRDS) 对成年ESRD患者 (1995-2010) 的数据.
- 包括来自美国一般人口的行为风险因素监测系统 (BRFSS) 的数据.
- 使用线性回归来比较两个人群之间的BMI趋势和斜率.
主要成果:
- 1995年至2010年间,ESRD患者的平均BMI增加了16.7% (从25.2增加到29.4).
- 在同一时期,美国普通人口的平均BMI增加了7.5% (从25.3到27.2).
- 在ESRD患者中,BMI的增加明显比美国一般人口更快 (p<0.001).
结论:
- 与美国一般人口相比,ESRD人口的平均BMI增长速度更快.
- 在ESRD患者中,肥胖与脏移植的可能性降低有关.
- 未来的研究应该集中在管理ESRD人口中的肥胖流行病的策略上,以控制医疗保健成本.
相关概念视频
Chronic Kidney Disease I: Introduction
36
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
36
Chronic Kidney Disease III: Interprofessional Care
42
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
42
Chronic Kidney Disease II: Clinical Manifestations
30
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
30
Chronic Kidney Disease IV: Nursing Management
25
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
25
Nephrotic Syndrome I : Introduction
9
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
11
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
11

